According to LabCorp's latest financial reports the company has $99.3 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.53 B | 67.44% |
2022-12-31 | $0.32 B | -78.23% |
2021-12-31 | $1.47 B | 11.5% |
2020-12-31 | $1.32 B | 291.35% |
2019-12-31 | $0.33 B | -20.92% |
2018-12-31 | $0.42 B | 34.81% |
2017-12-31 | $0.31 B | -26.98% |
2016-12-31 | $0.43 B | -39.48% |
2015-12-31 | $0.71 B | 23.52% |
2014-12-31 | $0.58 B | 43.56% |
2013-12-31 | $0.40 B | -13.45% |
2012-12-31 | $0.46 B | 193.03% |
2011-12-31 | $0.15 B | -30.95% |
2010-12-31 | $0.23 B | 55.35% |
2009-12-31 | $0.14 B | -32.41% |
2008-12-31 | $0.21 B | 32.11% |
2007-12-31 | $0.16 B | -11.02% |
2006-12-31 | $0.18 B | 196.2% |
2005-12-31 | $63.1 M | -69.49% |
2004-12-31 | $0.20 B | 68.13% |
2003-12-31 | $0.12 B | 118.09% |
2002-12-31 | $56.4 M | -62.2% |
2001-12-31 | $0.14 B |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
IDEXX Laboratories IDXX | $0.39 B | 300.23% | ๐บ๐ธ USA |
Quest Diagnostics
DGX | $0.47 B | 377.34% | ๐บ๐ธ USA |
Translate Bio
TBIO.defunct | N/A | N/A | ๐บ๐ธ USA |
NeoGenomics
NEO | $0.38 B | 287.54% | ๐บ๐ธ USA |
Qiagen QGEN | $0.89 B | 799.43% | ๐ณ๐ฑ Netherlands |
Enzo Biochem ENZ | $60.24 M | -39.33% | ๐บ๐ธ USA |